The Metabolic Control of Myeloid Cells in the Tumor Microenvironment
Myeloid cells are a key determinant of tumor progression and patient outcomes in a range of cancers and are therefore being actively pursued as targets of new immunotherapies. The recent use of high-dimensional single-cell approaches, e.g., mass cytometry and single-cell RNA-sequencing (scRNA-seq) h...
Enregistré dans:
Auteurs principaux: | Eloise Ramel, Sebastian Lillo, Boutaina Daher, Marina Fioleau, Thomas Daubon, Maya Saleh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8f57e36c95fc41128b29b93698117b9f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
par: Mojdeh Soltani, et autres
Publié: (2021) -
The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment
par: Maria Iorio, et autres
Publié: (2021) -
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
par: Seyed Mohammadreza Bolandi, et autres
Publié: (2021) -
Dysregulated Immunometabolism Is Associated with the Generation of Myeloid-Derived Suppressor Cells in Staphylococcus aureus Chronic Infection
par: Oliver Dietrich, et autres
Publié: (2021) -
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
par: Yaolin Xu, et autres
Publié: (2021)